相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Edward Seung et al.
NATURE (2022)
Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells
Gang Xue et al.
CANCER CELL (2021)
Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
Sundee Dees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
David Y. Oh et al.
IMMUNITY (2021)
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Amelie Cachot et al.
SCIENCE ADVANCES (2021)
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?
Justine Cinier et al.
CANCERS (2021)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response
Christopher S. Garris et al.
CLINICAL CANCER RESEARCH (2020)
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes
Shiwani Agarwal et al.
MOLECULAR THERAPY (2020)
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
David Y. Oh et al.
CELL (2020)
Identification of human CD4+ T cell populations with distinct antitumor activity
Michelle H. Nelson et al.
SCIENCE ADVANCES (2020)
CD4+ T-cell killing of multiple myeloma cells is mediated by resident bone marrow macrophages
Ole Audun W. Haabeth et al.
BLOOD ADVANCES (2020)
Dendritic cells in the tumor microenvironment: prognostic and theranostic impact
Johanna Verneau et al.
SEMINARS IN IMMUNOLOGY (2020)
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
Lintao Liu et al.
NATURE COMMUNICATIONS (2020)
Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy
Sai Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
CD4+ T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models
Bjarne Bogen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype
David Eisel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
Yong Lu et al.
CANCER CELL (2018)
CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs
Ole Audun W. Haabeth et al.
CANCER RESEARCH (2018)
Characterization of CD4+ T cell-mediated cytotoxicity in patients with multiple myeloma
Xiaole Zhang et al.
CELLULAR IMMUNOLOGY (2018)
Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity
Marte Fauskanger et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer
Sean G. Smith et al.
ONCOIMMUNOLOGY (2017)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
Thomas Kammertoens et al.
NATURE (2017)
The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response
Kun He et al.
CELL DEATH & DISEASE (2017)
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function
Arata Takeuchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
Ole Audun Werner Haabeth et al.
ONCOIMMUNOLOGY (2016)
Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response
Kristina Berg Lorvik et al.
CANCER RESEARCH (2016)
Tumour-specific CD4 T cells eradicate melanoma via indirect recognition of tumour-derived antigen
Elena Shklovskaya et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
Sarah E. Church et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
Ilseyar Akhmetzyanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Shigehisa Kitano et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
Connie Jackaman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
Daniel Hirschhorn-Cymerman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Macroimmunology and immunotherapy of cancer
Duane Hamilton et al.
IMMUNOTHERAPY (2009)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD41(+) T-cell immunity
Sara M. Mangsbo et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An NKT mediated autologous vaccine generates CD4 T-cell-dependent potent antilymphoma immunity
Yeonseok Chung et al.
BLOOD (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
CD8 T cell memory development: CD4 T cell help is appreciated
Aaruni Khanolkar et al.
IMMUNOLOGIC RESEARCH (2007)
Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12
S Homma et al.
IMMUNOLOGY (2005)
Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-γ, and eradicate tumor cells
L Broderick et al.
JOURNAL OF IMMUNOLOGY (2005)
Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity
CM Smith et al.
NATURE IMMUNOLOGY (2004)
Towards a cellular definition of CD8+ T-cell memory:: the role of CD4+ T-cell help in CD8+ T-cell responses
B Rocha et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination
N Casares et al.
JOURNAL OF IMMUNOLOGY (2003)
Human CD4(+) T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma
SD Hess et al.
JOURNAL OF IMMUNOLOGY (2003)
IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-γ
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
